The Comparative Analysis Between Motilitone and Gasmotin for the Symptom Relief in Gallstone Patients With Functional Dyspepsia

Launched by YONSEI UNIVERSITY · Apr 14, 2020

Keywords

ClinConnect Summary

At Severance Hospital, patients with cholelithiasis with symptoms of indigestion are divided into the Motilitone® and Gasmotin® groups. Provide sufficient oral and written explanation of the clinical trial and obtain consent from the patient who has revealed his willingness to participate. Randomization uses random numbers, and patient assignment by random numbers is managed by a third party who does not have direct contact with the patient or clinical history, and after obtaining consent, the group according to the random number is given and medication is given. It is provided to. Each dru...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. 19 years old to under 75
• • 2. Patients with dyspepsia in patients with cholelithiasis
• • 3. Patients who consented to this study and conducted questionnaires and tests during follow up
• Exclusion Criteria:
• • 1. asymptomatic cholelithiasis
• • 2. Gallstones over 3cm
• • 3. Acute cholecystitis requires surgery
• • 4. pregnant women
• • 5. porcelain gallbladder
• • 6. Chronic cholecystitis with severe thickening of the gallbladder wall
• • 7. Patients with anomalous pancreato-biliary duct union,
• • 8. When other physicians believe that surgery is necessary
• • 9. Patients with a history of hypersensitivity to "motilitone" or its components
• • ; Since this drug contains lactose, galactose intolerance, Patients with genetic problems such as Lapp lactase deficiency or glucose-galactose malabsorption.
• • 10. Hepatitis patients (Hepatitis carriers, cirrhosis patients) or suspected liver failure (AST, ALT levels are 1.5 times or more of normal values)